BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31325731)

  • 1. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
    Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
    Hill BT; Ahn KW; Hu ZH; Aljurf M; Beitinjaneh A; Cahn JY; Cerny J; Kharfan-Dabaja MA; Ganguly S; Ghosh N; Grunwald MR; Inamoto Y; Kindwall-Keller T; Nishihori T; Olsson RF; Saad A; Seftel M; Seo S; Szer J; Tallman M; Ustun C; Wiernik PH; Maziarz RT; Kalaycio M; Alyea E; Popat U; Sobecks R; Saber W
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):581-586. PubMed ID: 29032274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.
    Toze CL; Dalal CB; Nevill TJ; Gillan TL; Abou Mourad YR; Barnett MJ; Broady RC; Forrest DL; Hogge DE; Nantel SH; Power MM; Song KW; Sutherland HJ; Smith CA; Narayanan S; Young SS; Connors JM; Shepherd JD
    Br J Haematol; 2012 Jul; 158(2):174-185. PubMed ID: 22640008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
    Chavez JC; Kharfan-Dabaja MA; Kim J; Yue B; Dalia S; Pinilla-Ibarz J; Anasetti C; Locke FL
    Leuk Res; 2014 Oct; 38(10):1165-72. PubMed ID: 24889511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation.
    Lahoud OB; Devlin SM; Maloy MA; Roeker LE; Dahi PB; Ponce DM; Gyurkocza B; Koehne G; Young JW; Castro-Malaspina HR; Barker JN; Papadopoulos EB; Jakubowski AA; Zelenetz AD; Mato AR; Giralt SA; Perales MA; Sauter CS
    Blood Adv; 2021 Jul; 5(14):2879-2889. PubMed ID: 34297048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia (CLL) patients with the aberration of p53 gene].
    Wang L; Miao K; Fan L; Xu J; Wu H; Li J; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):308-12. PubMed ID: 27093994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
    Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
    J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.
    Huang SJ; Bergin K; Smith AC; Gerrie AS; Bruyere H; Dalal CB; Sugioka DK; Hrynchak M; Ramadan KM; Karsan A; Gillan TL; Toze CL
    Cancer Genet; 2017 Jan; 210():1-8. PubMed ID: 28212806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada.
    Huang SJ; Gerrie AS; Young S; Tucker T; Bruyere H; Hrynchak M; Galbraith P; Al Tourah AJ; Dueck G; Noble MC; Ramadan KM; Tsang P; Hardy E; Sehn L; Toze CL
    Leuk Res; 2020 Apr; 91():106335. PubMed ID: 32114372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.
    Goy J; Gillan TL; Bruyere H; Huang SJT; Hrynchak M; Karsan A; Ramadan K; Connors J; Toze CL; Gerrie AS
    Clin Lymphoma Myeloma Leuk; 2017 Jun; 17(6):382-389. PubMed ID: 28559149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.
    Machaczka M; Johansson JE; Remberger M; Hallböök H; Lazarevic VLj; Wahlin BE; Omar H; Wahlin A; Juliusson G; Kimby E; Hägglund H
    Med Oncol; 2013 Dec; 30(4):762. PubMed ID: 24214180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
    van Gelder M; Ziagkos D; de Wreede L; van Biezen A; Dreger P; Gramatzki M; Stelljes M; Andersen NS; Schaap N; Vitek A; Beelen D; Lindström V; Finke J; Passweg J; Eder M; Machaczka M; Delgado J; Krüger W; Raida L; Socié G; Jindra P; Afanasyev B; Wagner E; Chalandon Y; Henseler A; Schoenland S; Kröger N; Schetelig J;
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):667-675.e2. PubMed ID: 28694085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect.
    Bachireddy P; Ennis C; Nguyen VN; Gohil SH; Clement K; Shukla SA; Forman J; Barkas N; Freeman S; Bavli N; Elagina L; Leshchiner I; Mohammad AW; Mathewson ND; Keskin DB; Rassenti LZ; Kipps TJ; Brown JR; Getz G; Ho VT; Gnirke A; Neuberg D; Soiffer RJ; Ritz J; Alyea EP; Kharchenko PV; Wu CJ
    Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
    Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
    Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia.
    Moreno C; Villamor N; Colomer D; Esteve J; Martino R; Nomdedéu J; Bosch F; López-Guillermo A; Campo E; Sierra J; Montserrat E
    J Clin Oncol; 2005 May; 23(15):3433-8. PubMed ID: 15809449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.
    Richardson SE; Khan I; Rawstron A; Sudak J; Edwards N; Verfuerth S; Fielding AK; Goldstone A; Kottaridis P; Morris E; Benjamin R; Peggs KS; Thomson KJ; Vandenberghe E; Mackinnon S; Chakraverty R
    Br J Haematol; 2013 Mar; 160(5):640-8. PubMed ID: 23293871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
    Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
    Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease.
    Boyiadzis M; Foon KA; Pavletic S
    Expert Opin Biol Ther; 2007 Dec; 7(12):1789-97. PubMed ID: 18034645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.